The following pages link to Libin Rong (Q281121):
Displaying 50 items.
- Dynamics of an HIV model with multiple infection stages and treatment with different drug classes (Q281122) (← links)
- Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals (Q292757) (← links)
- A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data (Q433680) (← links)
- Permanence and extinction of a non-autonomous HIV-1 model with time delays (Q478670) (← links)
- Global stability of an infection-age structured HIV-1 model linking within-host and between-host dynamics (Q494449) (← links)
- Conflict and accord of optimal treatment strategies for HIV infection within and between hosts (Q669199) (← links)
- Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy (Q739681) (← links)
- Modeling the role of macrophages in HIV persistence during antiretroviral therapy (Q782891) (← links)
- New results on the robust stability of Cohen-Grossberg neural networks with delays (Q851879) (← links)
- Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips (Q1013286) (← links)
- Delay-independent stability analysis of Cohen-Grossberg neural networks (Q1409356) (← links)
- Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection (Q1624546) (← links)
- Modeling HIV persistence, the latent reservoir, and viral blips (Q1625882) (← links)
- HIV low viral load persistence under treatment: insights from a model of cell-to-cell viral transmission (Q1739472) (← links)
- Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor (Q1758099) (← links)
- Global exponential stability in Hopfield and bidirectional associative memory neural networks with time delays (Q1884132) (← links)
- Global dynamics and cost-effectiveness analysis of HIV pre-exposure prophylaxis and structured treatment interruptions based on a multi-scale model (Q1985085) (← links)
- Within-host viral dynamics in a multi-compartmental environment (Q2008277) (← links)
- Analysis of a stochastic HIV-1 infection model with degenerate diffusion (Q2008840) (← links)
- Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy (Q2013422) (← links)
- Dynamics of a new HIV model with the activation status of infected cells (Q2030254) (← links)
- Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance (Q2033746) (← links)
- A discrete stochastic model of the COVID-19 outbreak: forecast and control (Q2038649) (← links)
- A unified mathematical model of thyroid hormone regulation and implication for personalized treatment of thyroid disorders (Q2049203) (← links)
- The risk of future waves of COVID-19: modeling and data analysis (Q2092005) (← links)
- A two-sex model of human papillomavirus infection: vaccination strategies and a case study (Q2115993) (← links)
- Stochastic investigation of HIV infection and the emergence of drug resistance (Q2130165) (← links)
- The impact of vaccination on human papillomavirus infection with disassortative geographical mixing: a two-patch modeling study (Q2133939) (← links)
- Dynamics of an imprecise SIRS model with Lévy jumps (Q2156872) (← links)
- Optimal control in HIV chemotherapy with termination viral load and latent reservoir (Q2160595) (← links)
- Stochastic HIV model coupled with pharmacokinetics and drug adherence may explain intermittent viral blips (Q2161448) (← links)
- A delayed avian influenza model with avian slaughter: stability analysis and optimal control (Q2162083) (← links)
- A multiscale model of COVID-19 dynamics (Q2163837) (← links)
- A within-host drug resistance model with continuous state-dependent viral strains (Q2176469) (← links)
- A stochastic epidemic model with nonmonotone incidence rate: sufficient and necessary conditions for near-optimality (Q2200616) (← links)
- An age-structured model of HIV latent infection with two transmission routes: analysis and optimal control (Q2205918) (← links)
- Modeling the viral dynamics of SARS-CoV-2 infection (Q2207150) (← links)
- Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility (Q2219787) (← links)
- Modeling HIV multiple infection (Q2225977) (← links)
- Optimal vaccination strategy for an SIRS model with imprecise parameters and Lévy noise (Q2278960) (← links)
- Optimal control and cost-effectiveness analysis of a Zika virus infection model with comprehensive interventions (Q2279416) (← links)
- Analysis of an HIV model with immune responses and cell-to-cell transmission (Q2302045) (← links)
- Analysis of a stochastic SIRS model with interval parameters (Q2321132) (← links)
- Emergence of HIV-1 drug resistance during antiretroviral treatment (Q2426347) (← links)
- Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents (Q2435992) (← links)
- LMI-based criteria for robust stability of Cohen-Grossberg neural networks with delay (Q2478881) (← links)
- Modeling the impact of twitter on influenza epidemics (Q2514439) (← links)
- A dynamic model to assess human papillomavirus vaccination strategies in a heterosexual population combined with men who have sex with men (Q2659782) (← links)
- The impact of supplementary immunization activities on measles transmission dynamics and implications for measles elimination goals: a mathematical modelling study (Q2676079) (← links)
- Analysis of HIV models with two time delays (Q3300908) (← links)
